Effects of intraoperative low‐dose esketamine on postoperative pain after vestibular schwannoma resection: A prospective randomized, double‐blind, placebo‐controlled study
British Journal of Clinical Pharmacology · 2024
DOI: 10.1111/bcp.16081 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Kaizheng Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Eye & ENT Hospital, Fudan University, Fenyang, People's Republic of China. Hauptthemen laut MEDLINE: Ketamine, Postoperative Pain, Neuroma, Acoustic, Remifentanil. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Aims
Esketamine may reduce acute postoperative pain in several settings. However, the effects of low‐dose esketamine on postoperative pain after vestibular schwannoma (VS) resection with propofol/remifentanil total intravenous anaesthesia (TIVA) are unclear. The aim of this study is to observe the effects of intraoperative low‐dose esketamine on postoperative pain after vestibular schwannoma resection.
Methods
This single‐centre, randomized, placebo‐controlled, double‐blind trial included 90 adults undergoing VS resection via the retrosigmoid approach with TIVA. The patients were randomly allocated to two groups: esketamine or control (n = 45 in each group). Patients received low‐dose esketamine (0.2 mg/kg) or a similar volume of normal saline after dural closure. The primary outcome was the pain score during movement (gentle head movement) at 24 h postoperatively. Secondary outcomes included recovery time, bispectral index (BIS) values and haemodynamic profiles during the first 30 min after esketamine administration, and adverse effects.
Results
Low‐dose esketamine did not reduce pain scores at rest ( P > .05) or with movement ( P > .05) within the first 24 h after surgery. Esketamine moderately increased BIS values for at least 30 min after administration ( P < .0001) but did not affect heart rate (P = .992) or mean arterial blood pressure ( P = .994). Esketamine prolonged extubation time ( P = .042, 95% confidence interval: 0.08 to 4.42) and decreased the effect‐site concentration of remifentanil at extubation ( P = .001, 95% confidence interval: −0.53 to −0.15) but did not affect the time to resumption of spatial orientation. Postoperative nausea and vomiting rates did not differ between groups, and no hallucinations or excessive sedation was observed.
Conclusion
Intraoperative low‐dose esketamine did not significantly reduce acute pain after VS resection with propofol/remifentanil TIVA. However, BIS values increased for at least 30 min after esketamine administration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Eye & ENT Hospital, Fudan University, Fenyang, People's Republic of China.
- Department of Anesthesiology, Shanghai Sixth People's Hospital, Jiaotong University, Shanghai, China.
ORCID-Profile: Xia Shen
Zitieren
APA
Chen, K., Xie, Y., Chi, S., Chen, D., Ran, G., & Shen, X. (2024). Effects of intraoperative low‐dose esketamine on postoperative pain after vestibular schwannoma resection: A prospective randomized, double‐blind, placebo‐controlled study. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16081
Vancouver
Chen K, Xie Y, Chi S, Chen D, Ran G, Shen X. Effects of intraoperative low‐dose esketamine on postoperative pain after vestibular schwannoma resection: A prospective randomized, double‐blind, placebo‐controlled study. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.16081
BibTeX
@article{Chen2024,
author = {Chen, Kaizheng and Xie, Yaming and Chi, Songyuan and Chen, Dandan and Ran, Guo and Shen, Xia},
title = {Effects of intraoperative low‐dose esketamine on postoperative pain after vestibular schwannoma resection: A prospective randomized, double‐blind, placebo‐controlled study},
journal = {British Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1111/bcp.16081}
}
EUVIMED